Fiscal year ending 2025. Filed on September 11, 2025.
96 Cummings Point Road
Building
Stamford, Connecticut 06902
Alliance for Cancer Gene Therapy Inc. (EIN: 06-1619523) has filed an IRS Form 990 since fiscal year 2021. In its fiscal year 2025 IRS Form 990 filing, Alliance for Cancer Gene Therapy Inc., a 501(c)(3) charitable organization, reported compensation for 4 employees. Among the employees shown here, the average compensation is $248,302. The highest compensated employee at Alliance for Cancer Gene Therapy Inc. is Barbara Lavery with fiscal year 2025 compensation of $273,222.
Revenue
Expenses
Employee compensation
ACGT SUPPORTS HIGH-RISK, HIGH-REWARD SCIENTIFIC RESEARCH TO DEVELOP CANCER THERAPEUTICS THAT USE THE BODY'S OWN CELLS AND GENES AS A LIVING MEDICINE. BY ACCELERATING THIS RESEARCH, ACGT IS HELPING TO ADVANCE THERAPIES THAT ARE SIGNIFICANTLY MORE EFFECTIVE AND LESS TOXIC THAN CURRENT CANCER TREATMENTS SUCH AS CHEMOTHERAPY AND RADIATION.
Be the first to know when new IRS Form 990 data is published for this organization.